Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed.

1. A Pilot Proteomics Analysis ofInternational journal of molecular sciences · 2026
   Article
2. Microbial Dormancy and Reactivation in One Health: Cross-Domain Pathways and Risks.EcoHealth · 2026
   Review
3. ClpC1-dependent iron homeostasis underlies mycobacterial defense against oxygen-driven Fenton reaction during reactivation.Microbiology spectrum · 2026
   Article
4. Molecular basis of DosR-dependent transcription activation in Mycobacterium tuberculosis.Nature communications · 2026
   Article
5. Potential value of vitamin D as adjunctive therapy in osteoarticular tuberculosis: a comprehensive review.Infection · 2026
   Review
6. Multifaceted DosR proteins of Mycobacterium tuberculosis: emerging roles for tuberculosis control.Archives of microbiology · 2026
   Review
7. Exploring the Protein Landscape of Dormant Mycobacterium tuberculosis Through In Vitro Functional Studies.Advances in experimental medicine and biology · 2026
   Review
8. Lysine acetylome profiling reveals a dual regulatory role in carbon flux redirection and RNA degradation inhibition inFrontiers in microbiology · 2026
   Article
9. Dormant yet dangerous: the role of cell rest in perseverance.Future microbiology · 2025
   Review
10. Genomic landscape ofNew microbes and new infections · 2025
    Article
11. Pathogen virulence genes: Advances, challenges and future directions in infectious disease research (Review).International journal of molecular medicine · 2025
    Review
12. Recent advancements in drug development for pulmonary tuberculosis.Archives of microbiology · 2025
    Review
13. Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy.Advances in respiratory medicine · 2025
    Article
14. Advancement in diagnostic approaches for latent tuberculosis: distinguishing recent from remote infections.One health outlook · 2025
    Review
15. Unveiling the properties of ascorbic acid against M. tb through in silico approach: A comparative drug-based study.Journal of molecular modeling · 2025
    Article
16. In-silico development of a novel TLR2-mediating multi-epitope vaccine againstIn silico pharmacology · 2025
    Article
17. Human Gut Bacteriophageome: Insights Into Drug Resistance Mechanisms in Tuberculosis.Interdisciplinary perspectives on infectious diseases · 2025
    Review
18. Editorial: The role of transcriptional regulation in mycobacterium physiology.Frontiers in cellular and infection microbiology · 2024
    Article
19. Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update.British journal of biomedical science · 2024
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors.

Funding

Abstract

Indexed as